The Zika virus is spreading rapidly through the Americas and is causing an outbreak of birth defects in Puerto Rico and the United States.
This week, the U.S. Centers for Disease Control and Prevention announced a test for the Zika virus.
The Zika virus has been linked to birth defects, including microcephaly, a condition that causes small head circumference and brain damage.
Some experts say the Zika strain can spread through the air and into pregnant women, causing babies to be born with small heads.
The Zika strain is currently not detected in Puerto Rican newborns and newborns with microcepaly.
The new test is for people who are pregnant and have traveled to the Americas for the first time, including the U, S., Puerto Rico, U.K., France, Germany, the Netherlands, Brazil, Canada and the Dominican Republic.
The test is designed to be able to detect the Zika variant within 30 days of arriving in the U., S., U.P., Puerto Rican, Dominican Republic, Germany and France.
If the test shows the virus, it will be sent to the U and the U to be tested for the virus.
Puerto Rico has the highest rate of Zika infections in the Americas, according to data from the CDC.
The U.N. says that Puerto Rico is the most vulnerable region in the Caribbean and Latin America, with more than 500 cases of the Zika infection.
The CDC said that the test is not 100% effective, but the likelihood of being detected increases with time.
The tests can take anywhere from two to five weeks to be sent out.
It’s not yet known if Puerto Rico will get the test or if the test will take a few more weeks.
The U.C.P. of Puerto Rico has not sent out a test, though the UPA government said it has received one.
Pasadena-based vaccine company, Merck, announced this week it would offer a test to Puerto Rico for the second time in a month.
A new version of the vaccine, called RZO-0.5, is being developed for use in the country.
The RZo-0,5 vaccine is expected to go to the island in the coming weeks.
Merck said in a statement that the new vaccine has not been tested on pregnant women or newborns, though it has tested on people who have been pregnant or who have traveled from Puerto Rico.
Merck said the vaccine is more effective against Zika strains than any of the other vaccines currently available.